Q2 2023 Heartbeam Inc Earnings Call Transcript
Greetings and welcome to the HeartBeam second-quarter 2023 financial results conference call. (Operator Instructions) As a reminder, this conference is being recorded. At this time, I will turn the call over to HeartBeam's Chief Executive Officer, Branislav Vajdic. Please go ahead, sir.
Thank you, operator, and good afternoon, everyone. I am pleased to welcome you to today's second-quarter 2023 financial results conference call. On today's call, we will be releasing some very important updates about our business and our products.
Recently, we completed $26.5 million in funding, which will enable us to execute on upcoming product development, clinical, and regulatory milestones and extends our cash runway into late 2024. With this funding, we took the opportunity to adjust our strategic focus to enable timely delivery of our ambulatory vector electrocardiogram or VECG products, our key future value drivers.
Our first step is to obtain and 510(k) FDA clearance for the HeartBeam AIMIGo VECG
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |